RT Journal Article
SR Electronic
A1 Mosley, Mary
T1 Novel Oral Anticoagulants: Addressing the Clinical Conundra
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 20
SP 39
OP 40
DO 10.1177/155989771320018
UL http://mdc.sagepub.com/content/13/20/39.abstract
AB Four conditions drive the clinical conundrum regarding the use of novel oral anticoagulants in patients also receiving dual antiplatelet therapy (DAPT): atrial fibrillation, left ventricular and intracardiac thrombus, mechanical valve prosthesis, and venous thrombotic disease and pulmonary embolism. Recurrent thrombotic events in patients on DAPT also could be considered a legitimate addition to this list. This article reviews the evidence for treatment approaches.